Table 1. Comparison of AFX and UHPS
|
AFX |
MFH/UHPS |
Clinical presentation |
< 2cm, actinic damaged skin of head and neck, median age 69. |
> 5cm, deep soft tissues of proximal extremities (most frequently lower), not associated with actinic damage, median age 60 y/o. |
Location is tissue |
Dermal based tumor, can exhibit focal subcutaneous extension |
Subcutaneous or fascial based tumor, can exhibit dermal extension. More often associated with lymphovascular invasion & geographic necrosis |
Immunohistochemical staining |
CD99 (15- 100% ++/+++) PC1 (79%-87% +++) CD10 (92-100% +++) CD74 (90% -) |
CD99 (15-35% ++/+++) N/A CD10 (70% +++) CD74 (90% +++) |
Gene mutations |
P53 gene mutation |
H-ras and K-ras gene mutation in 2/8 cases studied |
Recurrence |
2-21% |
16-39% |
Metastases |
<1%; 58% lymph nodes, 35% visceral organs |
30-44%; 90% lungs |